Professor Edward Gregg
Chair in Diabetes and Cardiovascular Disease Epidemiology at Imperial College London
About this event
- Date and time Mon 11 Jul 2022 from 9:30am to 4:30pm
- Location Online
This is a live stream. To attend this event in person for free, please click here.
Join leading experts to hear about the state of diabetes care in 2022, and the latest developments in the research and treatment of complications.
Diabetes currently affects 4.9m people in the UK, and with diagnoses doubling in the last 15 years, estimates suggest that one in ten people in this country could have diabetes by 2030.
This conference held by the Royal Society of Medicine will offer insight into how the pandemic has changed Type-2 diabetes care, the causal links between Covid and diabetes, the latest data on prevention and remission, and what the future holds for the treatment of complications in secondary care.
During this event you will:
- Understand how Covid has changed the landscape of how Type-2 diabetes care is delivered
- Learn the latest information about the causal links between Covid and diabetes
- Explore the latest data on prevention and remission in the UK
- Gain updates on what’s new in in-patient care of diabetes
- Understand the latest developments in the research and treatment of a range of complications
The conference will feature presentations and panel discussions featuring expert speakers including Professor Edward Gregg, Dr Shivani Misra, Dr Chirag Bakhai, Professor Sobha Sivaprasad, Professor Jeremy Tomlinson, and Professor Andrew Boulton.
We would like to thank our sponsor Novo Nordisk for their support for this meeting. Novo Nordisk has provided sponsorship to the Royal Society of Medicine to support the costs of running this meeting. Novo Nordisk has had no influence over the meeting arrangements, agenda or selection of speakers apart from the Novo Nordisk symposium.
Key speakers
Dr Chirag Bakhai
Primary Care Lead for the NHS England Diabetes Programme
Professor Sobha Sivaprasad
Consultant Ophthalmologist, Moorfields Eye Hospital and King’s College Hospital, London
Professor Andrew Boulton
President of the International Diabetes Federation and Consultant Physician at the Manchester Royal Infirmary
Agenda
View the programme
Registration, tea and coffee
Welcome to the conference
Professor Roger Kirby, President of the Royal Society of Medicine
Session 1: Diabetes in 2022: Where are we now?
Chair: Dr Stella George FRCP, Consultant Diabetes and Endocrinology, Clinical Director Diabetes and Endocrinology, East and North Herts NHS Trust, University of Cambridge. President, Diabetes and Endocrinology Section, Royal Society of Medicine
How has Covid changed diabetes?
Professor Edward Gregg, Professor and Head of School of Population Health, Royal College of Surgeons of Ireland, University of Medicine and Health Sciences, and Chair in Diabetes and Cardiovascular Disease Epidemiology at the Professor and Head School of Public Health, Imperial College London
Panel discussion: Links between Covid and diabetes
Chair: Professor Dr Gerry Rayman, Consultant Physician at the Diabetes and Endocrine Centre, Ipswich Hospitals NHS Trust
Dr Shivani Misra, Consultant in Metabolic Medicine & Diabetes, Imperial College Healthcare NHS Trust
Professor Edward Gregg, Professor and Head of School of Population Health, Royal College of Surgeons of Ireland, University of Medicine and Health Sciences, and Chair in Diabetes and Cardiovascular Disease Epidemiology at the Professor and Head School of Public Health, Imperial College London
Tea and coffee break
Diabetes prevention and remission: The latest data from the NHS programmes
Dr Chirag Bakhai, Primary Care lead for the NHS England Diabetes Programme
Inpatient diabetes: What’s new
Professor Ketan Dhatariya, Consultant in Diabetes, Endocrinology and General Medicine, Norfolk and Norwich University Hospital and past-President of the RSM’s Endocrinology and Diabetes section
Novo Nordisk Symposium Session on 'Collaborative working to support people living with Type 2 Diabetes'
The Novo Nordisk symposium has been organised and funded by Novo Nordisk and is for UK health professionals (lunch will be provided)
Networking
Session 2: Complications: The latest research, treatments and what the future holds
Chair:
Dr Sheba Jarvis, Honorary Consultant in Endocrinology, Diabetes Obstetric Medicine, GIM Imperial College Healthcare NHS Trust
Professor Dr Gerry Rayman, Consultant Physician at the Diabetes and Endocrine Centre, Ipswich Hospitals NHS Trust
Obesity
Dr Alex Miras, Professor of Endocrinology at Ulster University, Visiting Professor at Imperial College London.
Cardiac complications
Prof Vassilios Vassiliou, Clinical Professor and Consultant Cardiologist, University of East Anglia
Liver disease
Professor Jeremy Tomlinson, Metabolic Endocrinology and Consultant Endocrinologist, Oxford Centre for Diabetes, Endocrinology and Metabolism
Q&A with speakers
Break
Eye disease
Professor Sobha Sivaprasad, Consultant Ophthalmologist, Moorfields Eye Hospital and King's College Hospital
Kidney disease
Dr Kieran McCafferty, Consultant Nephrologist, Barts Health NHS Trust, and Senior Lecturer, Queen Mary University London
Nerve damage
Professor Andrew Boulton, Professor of Medicine with a special interest in diabetes and its complications at the University of Manchester and Consultant Physician
Q&A with speakers
Closing remarks
Complimentary drinks reception
Sponsors
Location
Online
Registration for this event will close on Monday 11 July 2022 at 07:30am. Late registrations will not be accepted.
The agenda is subject to change at any time.
All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.
We are only able to share presentations that we have received permission to share. This is at the presenter and the RSM’s discretion.
This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.
